FOLLOW US

  • facebook
  • twitter
Tue

March 23, 2026

Gilead To Buy CymaBay For $4.3B

America February 12, 2024

Gilead To Buy CymaBay For $4.3B : A Liver Health Power Play

In a bold move poised to reshape the landscape of liver disease treatment, Gilead Sciences Inc. has announced its acquisition…

By Rihem Akkouche

GSK Sells £978M Worth Of Shares in Haleon PLC

America January 17, 2024

GSK Sells £978M Worth Of Shares in Haleon PLC

In a strategic financial move, pharmaceutical powerhouse GSK (formerly GlaxoSmithKline) announced on Wednesday that it has successfully divested a significant…

By Rihem Akkouche

GSK To Buy Drug Biz For $1.4B

America January 9, 2024

GSK To Buy Drug Biz For $1.4B: Deal to Acquire Aiolos Bio Inc. Unveiled

In a bold move to bolster its respiratory treatments arsenal, GSK PLC, the British pharmaceutical giant, announced a groundbreaking deal…

By Rihem Akkouche

first 10 Drugs For Negotiations

America August 29, 2023

The First 10 Drugs For Negotiations Unveiled Amidst Legal Frenzy

In a significant move bound to ripple through the healthcare landscape, the U.S. Department of Health and Human Services (HHS)…

By Rihem Akkouche

Business October 5, 2020

Bristol Myers Squibb to Acquire MyoKardia for $13.1 Billion

Bristol Myers Squibb (NYSE: BMY) announced that it will buy MyoKardia Inc. (NASDAQ: MYOK) for $13.1 billion or $225 per…

By Sean Corliss

Signup for the USA Herald
exclusive Newsletter